|Articles|November 1, 1999
Supplements and Featured Publications
- The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
- Volume 5
- Issue 17 Suppl
Participating Faculty
Advertisement
Articles in this issue
about 26 years ago
Introductionabout 26 years ago
Epidemiology of Pneumococcal Diseaseabout 26 years ago
The Costs of Antimicrobial Treatment Failure in Acute Otitis Mediaabout 26 years ago
Prevention of Pneumococcal Disease in High-Risk Pediatric Groupsabout 26 years ago
The Clinical Impact of Pneumococcal Conjugate Vaccinesabout 26 years ago
Economic Impact of Pneumococcal Conjugate Vaccine in Managed Careabout 26 years ago
Into the Era of the Pneumococcal Conjugate Vaccineabout 26 years ago
Selected Abstractsabout 26 years ago
CME Quizabout 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates
2
ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care
3
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
4
Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
5
